Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With HeberprovacJesús A. Junco, Marta Ayala, Marı́a D. Castro et al.|Frontiers in Oncology|2019Cited by 19
Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer modelJesús Arturo Junco Barranco, Gerardo Guillén, Robert P. Millar et al.|Oncology Letters|2016Cited by 5